drugset / Trial / NCT00788827
Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant
NaSingle-groupOpen-labelTreatment
Summary
This is a phase I study to assess the safety and tolerability of infusing expanded stem cells into the pancreas of patients with type I diabetes and a successful renal transplant. The stem cells used in this study occur naturally in the body and are collected from each recipient by a procedure called leukapheresis. The cells are then expanded and differentiated into insulin-like cells in a sterile suite before being injected into the body or tail of the pancreas of the recipient.
Timeline
- Start
- 2008-11
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous CD34+ stem cells | Cell therapy | 5e+08 cells | Other |